4//SEC Filing
BAKER DOUGLAS P 4
Accession 0001213900-21-043479
CIK 0001448431other
Filed
Aug 16, 8:00 PM ET
Accepted
Aug 17, 4:46 PM ET
Size
6.4 KB
Accession
0001213900-21-043479
Insider Transaction Report
Form 4
OptimizeRx CorpOPRX
BAKER DOUGLAS P
Chief Financial Officer
Transactions
- Sale
Common Stock (pursuant to 10B5-1 plan)
2021-08-17$58.46/sh−4,000$233,840→ 63,796 total - Sale
Common Stock (pursuant to 10B5-1 plan)
2021-08-13$63.27/sh−5,000$316,350→ 67,796 total
Footnotes (2)
- [F1]These shares sold pursuant to a plan of disposition adopted on June 18, 2021 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.
- [F2]These shares sold pursuant to a plan of disposition adopted on May 11, 2021 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.
Documents
Issuer
OptimizeRx Corp
CIK 0001448431
Entity typeother
Related Parties
1- filerCIK 0001028775
Filing Metadata
- Form type
- 4
- Filed
- Aug 16, 8:00 PM ET
- Accepted
- Aug 17, 4:46 PM ET
- Size
- 6.4 KB